Table 2. Antimicrobial susceptibility profiling and phenotypes of staphylococci as identified by the Phoenix Automated Identification System (n = 38).
| Antibiotic agent | No. and Proportion (%) |
|---|---|
| Gentamicin | 2MRS (5.2%) |
| Imipenem | 13MRS (34.2%) |
| Cefoxitin | 13MRS (34.2%) |
| Cefotaxime | 12MRS (6%) |
| Ampicillin | 33(86.8%) |
| PenicillinG | 33(86.8%) |
| Oxacillin | 13MRS (34.2%) |
| Amoxicillin-Clavulanate | 13MRS (34.2%) |
| Daptomycin | 0(0%) |
| Trimethoprim-Sulfamethoxazole | 1MRS (2.6%) |
| Teicoplanin | 0(0%) |
| Vancomycin | 2(5.2%) |
| Clindamycin | 3(7.8%) |
| Erythromycin | 1MRS-MLSB(2.6%) |
| Fusidic acid | 0 (0%) |
| Linezolid | 0 (0%) |
| Mupirocin | 0 (0%) |
| Nitrofurantoin | 0 (0%) |
| Ciprofloxacin | 1MRS (2.6%) |
| Moxaifloxacin | 0 (0%) |
| Rifampin | 0 (0%) |
| Tetracycline | 0 (90%) |
(MRS) = methicillin-resistant staphylococci; (MLSB) = macrolide-lincosamide-streptogramin B resistance.